Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Medicare Advantage could become the default health-insurance program for all older adults. A recent proposal in Congress would automatically enroll older adults in a Medicare Advantage plan and then ...

A bill introduced by Rep. Buddy Carter would ban PBMs’ use of spread pricing in Medicaid, among other reforms.

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Humana on Monday filed a new lawsuit over the U.S. government's reduction in the health insurer's star ratings for government ...

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Humana (HUM) stock falls as the company loses a lawsuit over its 2025 Medicare Star Ratings cut. Read more here.

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

Maryland Physicians Care, which is being sued by the University of Maryland Medical System for $15 million, moved the suit to federal court.

CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement System, known as Calpers.